Sharon Klahre | Head, IR |
Michael Metzger | CEO |
Neil Gallagher | President & Head, R&D |
Keith Goldan | CFO |
Peter Ordentlich | CSO |
Anjali Ganguli | CBO |
Phil Nadeau | TD Cowen |
Anupam Rama | JPMorgan |
Ashiq Mubarack | Citi |
Brad Canino | Stifel |
Michael Schmidt | Guggenheim |
Peter Lawson | Barclays |
William Wood | B. Riley Securities |
Justin Zelin | BTIG |
Good day, everyone, and welcome to the Syndax Second Quarter 2023 Earnings Conference Call. Today's call is being recorded.
At this time, I would like to turn the call over to Sharon Klahre, Head of Investor Relations at Syndax Pharmaceuticals. Please go ahead.
Thank you, Operator.